Scientists investigate why some preemies develop deadly gut disease
NCT ID NCT00747851
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is collecting and analyzing immune cells from the umbilical cord blood of premature and full-term newborns. Researchers want to understand how these cells respond to certain inflammatory signals, which may help explain why some premature babies develop necrotizing enterocolitis (NEC), a serious gut infection. The study will follow premature infants to see who gets NEC and what factors might be involved.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could point toward ways to predict or prevent necrotizing enterocolitis in premature infants.
- What could go wrong
- This is an early, observational lab study, not a treatment trial. It may not lead directly to new therapies or change clinical practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NECROTIZING ENTEROCOLITIS (NEC) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Utah
RECRUITINGSalt Lake City, Utah, 84112, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.